Safety, Tolerability, Pharmacokinetics And Measurement Of Whole Blood Activity (WBA) Of PNU-100480 After Multiple Oral Doses In Healthy Adult Volunteers

NCT00990990 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: PNU-100480
DRUG: Placebo
DRUG: PNU-100480
DRUG: Placebo
DRUG: PNU-100480
DRUG: Placebo
DRUG: PNU-100480
DRUG: Placebo
DRUG: PNU-100480
DRUG: Placebo
DRUG: PNU-100480
DRUG: Placebo
DRUG: Linezolid

Sponsor

Sequella, Inc.